Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merus N.V.
DescriptionHuman bispecific IgG antibody targeting CD3 expressed by T cells and an undisclosed target expressed by multiple myeloma cells
Molecular Target CD3
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today